Latest Funding News

Xstate Resources has issued a cleansing prospectus to remove trading restrictions on recently placed shares and associated options, following a $1.69 million capital raise priced at 3.3 cents per share. The offer includes free attaching options to placement participants, brokers, and consultants, subject to shareholder approval.

InvestSMART Group’s total Funds Under Management fell to $712 million in Q3 FY2026, weighed down by market dips and underperforming ETFs, even as subscriber revenue nudged higher and account numbers grew.

Lion Energy has secured funding for its East Seram Bula Karang-1 exploration well, reduced capital risk by divesting its Seram (Non-Bula) PSC stake, and put green hydrogen development on hold pending commercial clarity.

Hastings Technology Metals is on track to commission its Kabin Buri Hydromet Plant in Thailand by June 2026, aiming for first production of premium Mixed Rare Earth Chloride flakes by Q4. The plant promises near-term revenue streams and leverages lower operating costs in Thailand's Eastern Economic Corridor.

Multistack International is progressing with the sale of its core assets to Willing Y Limited, maintaining operations cautiously while cash reserves decline amid ongoing operating losses.

Emu NL has secured $1.63 million from its recent rights issue to fund a 10,000-metre drilling program targeting copper anomalies at Yataga Valley, while a $2 million shortfall remains unplaced.

333D Ltd (ASX:T3D) reversed its prior quarter’s cash outflow to report a $71,505 positive operating cash flow for March 2026, driven by growing healthcare digital asset contracts and a strategic Bitcoin holding. The company also deployed $95,800 post-quarter to scale its healthcare-focused platform.

Qube Holdings has obtained an ASX waiver allowing it to deviate from the standard scheme of arrangement timetable, enabling a fully franked special dividend payment and accommodating bidder funding arrangements. The board unanimously recommends shareholder approval, contingent on independent expert support and absence of superior proposals.

Airtasker Limited posted robust 3Q26 results highlighted by strong Australian marketplace momentum and explosive growth in the UK and US. The company reaffirmed its FY26 guidance, underpinned by strategic media partnerships and a solid cash position.

Manhattan Gold Corporation has secured A$3 million to kick off a 4,000m reverse circulation drilling program at its Hook Lake Project in Nunavut, Canada, while expanding its exploration area by 81km² with new mineral claims covering high-grade gold anomalies.

Alterity Therapeutics has unveiled fresh Phase 2 data revealing ATH434’s ability to slow functional decline in Multiple System Atrophy patients, measured by the novel MuSyCA scale. This reinforces the drug’s disease-modifying potential ahead of pivotal Phase 3 trials.

VHM Limited has raised A$5 million through a discounted institutional placement to accelerate early engineering and procurement for its Goschen Rare Earth and Mineral Sands Project ahead of a mid-2026 Final Investment Decision.